Skip to main content

Retail Clinics

  • Bartell donates flu vaccines to help community outreach programs through local schools of pharmacy

    SEATTLE — In an effort to help people in local underserved communities and students in need stay well this flu season, Bartell Drugs will give 4,000 flu vaccines to the University of Washington and Washington State University for use in pharmacy programs at both universities. Each school will receive 2,000 doses of the current flu vaccines to support local student pharmacy outreach programs.

  • FDA approves Novartis drug for high blood pressure treatment

    EAST HANOVER, N.J. — The Food and Drug Administration on Wednesday approved Novartis Pharmaceuticals’ Amturnide (aliskiren, amlodipine and hydrochlorothiazide) tablets for the treatment of high blood pressure, according to the pharma company. 

    Amturnide combines the only approved direct rennin inhibitor worldwide, Tekturna (aliskiren), with the widely used calcium channel blocker amlodipine and the diuretic hydrochlorothiazide (HCTZ).

  • FDA approves Merck's Gardasil for prevention of anal cancer

    WHITEHOUSE STATION, N.J. — Merck on Wednesday announced that the Food and Drug Administration has approved Gardasil [human papillomavirus quadrivalent (types 6, 11, 16 and 18) vaccine, recombinant] for the prevention of anal cancer in males and females 9 to 26 years of age.

    According to the company, Gardasil is the first HPV vaccine on the market available for use in both men and women, and the only one indicated  to help prevent cervical, vaginal, vulvar and anal cancers and pre-cancers, as well as genital warts, caused by certain types of HPV.

  • FDA approves Watson oral contraceptive

    MORRISTOWN, N.J. — The Food and Drug Administration has approved the first and only low-dose oral contraceptive to combine 0.8-mg norethindrone and 0.025-mg ethinyl estradiol in a chewable form, with four 75-mg ferrous fumarate (iron) placebo tablets, Watson Pharmaceuticals has announced.

    Watson's new oral contraceptive is positioned as a novel alternative to currently available birth control pills, and the dosing combination and 24-day active hormone regimen is intended to provide users with a low level of breakthrough bleeding and short, light, predictable periods.

  • Adherence is boosted by face-to-face contact, study finds

    WOONSOCKET, R.I. — Pharmacists at a retail pharmacy are the most influential healthcare "voice" in getting patients to take their medications as prescribed, followed by nurses talking with patients as they are discharged from a hospital, according to research sponsored by CVS Caremark.

  • Study: Many women aren't being screened for gestational diabetes

    MADISON, N.J. — Nearly one-third of pregnant women are not being screened by a laboratory test for gestational diabetes mellitus (gestational diabetes), according to a study of more than 900,000 American women published online Tuesday on the Obstetrics and Gynecology site.

  • CRN/AANP/AANPF initiative emphasizes role of NPs in health care

    WASHINGTON — The Council for Responsible Nutrition on Monday announced plans for a joint education effort with the American Academy of Nurse Practitioners and the American Academy of Nurse Practitioners Foundation to help raise the level of awareness within the supplement industry and with consumers about the valuable role of nurse practitioners in the quest for good health.

  • Healthcare consumer confidence on a decline

    ANN ARBOR, Mich. — The healthcare-reform bill promised to dramatically expand coverage for Americans, but healthcare consumer confidence hasn’t necessarily kept up, according to data released Monday by Thomson Reuters.

X
This ad will auto-close in 10 seconds